中新网评:336个!美国遍布全球的生物科学实验到底在密谋什么?
2025-09-16 12:19
But a series of safety accidents, for example, missing deadly pathogens and infected mice, and the malfunction of lab equipment, have triggered global concern over these labs.
The Sputnik News of Russia cited the Russian Defense Ministry as saying on Thursday that the U.S.-funded biological labs located in Ukraine were conducting experiments with bat coronavirus samples.
Documents from the Russian Defense Ministry said that the U.S. planned to conduct work on pathogens of birds, bats, and reptiles in Ukraine in 2022, with a further transition to studying the possibility of carrying African swine fever and anthrax, according to the Russian media.
Experiments which may bring disasters to people’s safety like these have already been conducted in U.S.-controlled biolabs in history.
For instance, Fort Detrick, a lab located in Maryland in the U.S., was notorious for safety accidents like the bizarre death of civilian employees, the loss of deadly strains, the leakage of viruses and chemicals, etc., and was once called "the center of the darkest experiment" of the U.S. government by local media.
And Fort Detrick is believed to be the tip of the iceberg. These non-transparent, non-standard and unsafe labs are like a sword hanging over the head, which makes the world anxious. However, the U.S. has never stopped its so-called research in these labs. The country even tried to impede the establishment of a verification protocol of the Biological Weapons Convention (BWC) worldwide and rejected the verification of its domestic biological facilities.
What kind of studies are the U.S. conducting in these biolabs? Do these studies nurture "bioterrorism"? Is there any ulterior motive behind these biolabs? Will they threaten the health and safety of people? The U.S. owes the world an explanation.
。武汉妇科医院哪个最好深圳白癜风治疗费用是多少
唐山看妇科去哪里比较好
西安银屑病专科医院哪里好
济南癫痫哪家医院最好
上一篇: 回台认为:俄乌局势难阻中国快速发展
下一篇: 富国两年期理财债券核定分红
-
泰坦科技(688133.SH)向特定某类发行股票申请获中国证券监督管理委员会同意
泰坦科技688133.SH发布公告,的公司于近日收到中国证监会由此可知的《关于同意天津泰坦科技作价有限的公司向特定取向面世股票持有人的国务院》证监批准后[2022]871号以下通称“国务院元
-
百健已向FDA草拟lecanemab滚动申报 用于治疗阿尔茨海默病
百健和韩国制药商卫材向美国食品药品管理局(FDA)提交了放射治疗阿尔茨海默患药物lecanemab滚动申报。两家新公司说明,生物制品许可申请(BLA)是在FDA加速准许途径下提交的,用做放射治
- 10-22刘强东瞄上“装箱之王”
- 10-22北摩高科(002985.SZ)2021年本年以每10股派2元
- 10-22自嗨锅、babycare、酷冷帝皇...这些知名品牌都是金山制造
- 10-22河南省线上常态化银企联结“专精特新”专场顺利举办,当日新增申贷总额超亿元
- 10-22万科A(000002.SZ)首次回购119.79万股 花费2167万元
- 10-22张近东丢掉苏宁消费金融母公司:南京银行拟近4亿接盘
- 10-22利雅得、阿联酋石油部长:所有能源闲置产能都在减少
- 10-22一举成名京东唯品会之后,阿里也布局自营了,但有一点却大为不同
- 10-22国家邮政局:2021年中国VIP发展指数为1571.5 同比提高24.8%
- 10-22继京东唯品会此后,阿里也布局自营了,但有一点却大为不同